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Abstract
Background: There is a wealth of evidence regarding the detrimental impact of excessive alcohol
consumption on the physical, psychological and social health of the population. There also exists a
substantial evidence base for the efficacy of brief interventions aimed at reducing alcohol
consumption across a range of healthcare settings. Primary research conducted in emergency
departments has reinforced the current evidence regarding the potential effectiveness and cost-
effectiveness. Within this body of evidence there is marked variation in the intensity of brief
intervention delivered, from very minimal interventions to more intensive behavioural or lifestyle
counselling approaches. Further the majority of primary research has been conducted in single
centre and there is little evidence of the wider issues of generalisability and implementation of brief
interventions across emergency departments.
Methods/design: The study design is a prospective pragmatic factorial cluster randomised
controlled trial. Individual Emergency Departments (ED) (n = 9) are randomised with equal
probability to a combination of screening tool (M-SASQ vs FAST vs SIPS-PAT) and an intervention
(Minimal intervention vs Brief advice vs Brief lifestyle counselling). The primary hypothesis is that
brief lifestyle counselling delivered by an Alcohol Health Worker (AHW) is more effective than
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BMC Health Services Research 2009, 9:114 http://www.biomedcentral.com/1472-6963/9/114Brief Advice or a minimal intervention delivered by ED staff. Secondary hypotheses address
whether short screening instruments are more acceptable and as efficient as longer screening
instruments and the cost-effectiveness of screening and brief interventions in ED. Individual
participants will be followed up at 6 and 12 months after consent. The primary outcome measure
is performance using a gold-standard screening test (AUDIT). Secondary outcomes include;
quantity and frequency of alcohol consumed, alcohol-related problems, motivation to change,
health related quality of life and service utilisation.
Discussion: This paper presents a protocol for a large multi-centre pragmatic factorial cluster
randomised trial to evaluate the effectiveness and cost-effectiveness of screening and brief
interventions for hazardous alcohol users attending emergency departments.
Trial Registration: ISRCTN 93681536
Background
Prevalence of alcohol use disorders
The recent Alcohol Needs Assessment Research Project for
England (ANARP) reported that 26% (38% of men and
16% of women) of the population of England aged 16–64
have an alcohol use disorder (AUD), equivalent to
approximately 8.2 million people [1]. Alcohol use disor-
ders include hazardous drinking, harmful drinking and
alcohol dependence. The prevalence of alcohol depend-
ence overall was 3.6%, with 6% of men and 2% of women
meeting these criteria nationally, which equates to 1.1
million people. The rising patterns in consumption sug-
gest that the prevalence of AUD will increase significantly
over the next ten years, which poses a significant threat to
the health of the UK population.
Over 14 million people are treated in Emergency Depart-
ments (ED) in England each year, of which 35% of attend-
ances are alcohol related at a cost of over £0.5 billion per
year [2]. Furthermore, a recent survey of 32 EDs in Eng-
land found that up to 40% of admissions at weekends and
up to 70% at peak times were alcohol related [2]. The high
levels of attendances can be explained by the link between
excessive drinking and a greater risk of being involved in
accidents, assaults, fights and other traumatic events
requiring hospital care [3-5]. The vast number of patients
that visit ED each year with or without alcohol related
presentations offers the opportunity to access and inter-
vene with a large number of patients who may misuse
alcohol.
Current evidence for screening and brief interventions
A wide array of screening methods has been developed
including verbal instruments or questionnaires. Examples
of paper based questionnaires include the Alcohol Use
Disorders Identification Test, AUDIT [6], Fast Alcohol
Screening Test, FAST [7], Michigan Alcoholism Screening
Test [8] and the Paddington Alcohol Test, PAT [9]. All
have an acceptable, and in some cases a remarkably high,
level of sensitivity and specificity compared to more com-
plex research measures of excessive drinking and alcohol
use disorders. For example a recent UK primary care study
using the AUDIT found it to have 92% sensitivity and
92% specificity for hazardous and harmful drinking com-
pared with a Time Line Follow Back (gold standard) meas-
ure of alcohol consumption [10]. Questionnaire methods
of screening are considerably more valid and cost effective
than blood screening methods [10]. However, the various
methods differ in several respects: CAGE and FAST are 4
item measures; AUDIT is 10; the PAT is designed to be
incorporated into routine ED assessment, whereas the
FAST has been tested primarily in a research context of
universal screening. This has led to the development of
shorter variants of questionnaires for use in busy clinical
settings (e.g. FAST and AUDIT C are shorter versions of
AUDIT). Indeed some US studies showed that a single
item measure of excessive drinking (SASQ) had 86% sen-
sitivity and specificity for alcohol use disorders [11,12].
Further, recent pilot work using focus groups in primary
care showed that healthcare practitioners were more likely
to adopt shorter instruments, that were simpler to score
and that were less disruptive to clinical practice. The
poorer screening performance of shorter instruments of
lower sensitivity may be offset in the typical busy clinical
situation by greater use by practitioners. Further, ques-
tionnaire items that enquire simply about alcohol con-
sumption, particularly when embedded in a general
health and lifestyle questionnaire, are more likely to be
acceptable to clinicians and patients as being less stigma-
tizing.
Similarly, whilst much of the research on alcohol screen-
ing methods has been carried out in a universal screening
paradigm there is evidence to suggest that targeted screen-
ing, restricted to higher risk individuals, is more accepta-
ble to practitioners [13]. Indeed PAT has been designed to
be used among patients with one of 10 common alcohol
related conditions presenting to ED and so functions as a
targeted screening approach. Pre-screens involving
enquiry about medical conditions associated with alcoholPage 2 of 10
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clinicians. However, it is currently unclear which
approach, universal or targeted screening, is more effec-
tive and cost-effective in the ED setting, hence the need to
evaluate this issue in our trial.
There exists a substantial evidence base for the efficacy of
brief interventions aimed at reducing alcohol consump-
tion across a range of healthcare settings [14]. A review
focusing upon the delivery of brief interventions in acci-
dent and emergency departments [15] concluded that the
evidence was such that "...screening and brief intervention
for alcohol-related problems in the Emergency Department be
incorporated into clinical practice" (p627). Primary research
conducted in accident and emergency departments has
reinforced the current evidence regarding the potential
effectiveness [16-19] and cost-effectiveness [20,21].
Within this body of evidence there is marked variation in
the intensity of brief intervention delivered, from very
minimal interventions to more intensive behavioural or
lifestyle counselling approaches. Further the majority of
primary research has been conducted in single centre and
there is little evidence of the wider issues on generalisabil-
ity and implementation of brief interventions across acci-
dent and emergency departments.
Public health policy context
This research is designed to support the National Alcohol
Harm Reduction Strategy for England which has called for
"more information...on the most effective methods of tar-
geted screening and brief interventions, and whether the
successes shown in research studies can be replicated
within the health system in England" [22]. This project
aims to address these issues to provide evidence on the
delivery, effectiveness and cost effectiveness of a range of
alcohol screening and brief intervention approaches
across settings and regions in England. It is envisaged that
the results of the study will have implications for the
implementation and delivery of screening and brief inter-
ventions in an international context.
Aims of the study
The aim of this study is to evaluate the implementation,
effectiveness and cost effectiveness of brief intervention to
reduce excessive drinking in hazardous and harmful
drinkers identified by universal or targeted screening
delivered by an Alcohol Health Worker (AHW) in routine
ED care compared to brief advice and a patient informa-
tion leaflet (PIL) delivered by ED staff.
The objectives of the trial are:
• To conduct a pragmatic multicentre cluster ran-
domised controlled trial of screening and brief inter-
ventions for hazardous and harmful drinkers in EDs in
three English regions.
• To compare the effectiveness and cost effectiveness
of brief advice given by ED staff with referral to an
AHW of patients with hazardous and harmful alcohol
consumption identified by targeted opportunistic or
universal screening.
• To assess the relative impact of the three implemen-
tation strategies on alcohol screening and brief inter-
vention activity in EDs.
• To identify the attitudinal, practical, skill, resource
and reinforcing factors that act as prognostic indica-
tors of successful implementation of screening and
brief intervention in ED.
• To identify the optimal method of alcohol screening
in ED.
• To assess the relative impact of the three implemen-
tation strategies on uptake of alcohol services, includ-
ing an alcohol helpline.
Methods/design
The study is a pragmatic factorial cluster randomised trial.
The study has been granted ethical approval by the Lon-
don Research Ethics Committee ref: 07/MRE02/06. The
study complies with the Helsinki declaration. A full flow
diagram for the study is shown in Figure 1.
A number of methodological considerations have been
taken into account in designing this study. First, we are
conducting in the main a pragmatic rather than an explan-
atory trial because our focus is primarily upon decision
making rather than understanding. Second, we are con-
ducting an effectiveness trial rather than an efficacy trial;
our aim is to maximise generalisability of our findings to
usual clinical practice and we therefore have maximised
external validity. Third, we are concerned about the
potential of contamination within ED in terms of both
the screening mechanism and the intervention and there-
fore we have chosen to use cluster randomisation with the
ED as the unit of randomisation. Fourth, we aim to evalu-
ate three screening tools (M-SASQ vs FAST vs SIPS-PAT)
and three levels of intervention (Minimal intervention vs
Brief advice vs Brief lifestyle counselling). This 3 × 3 facto-
rial design allows both screening method and interven-
tion to be analysed separately with sufficient statistical
power and for the analysis of any potential interactions
between screening method and intervention.Page 3 of 10
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• Brief lifestyle counselling (BLC) by an AHW for haz-
ardous and harmful drinkers identified by screening is
more effective and cost effective than brief advice (BA)
conducted by ED staff in the typical ED setting.
• Brief lifestyle counselling by an AHW and brief
advice by ED staff are more effective and cost effective
than an information leaflet alone (PIL).
• Deployment of an AHW results in greater screening
and intervention activity than training of ED staff in
screening and brief intervention alone.
• Briefer screening methods result in greater imple-
mentation of screening activity than more complex
methods.
Trial inclusion and exclusion criteria
Inclusion and exclusion criteria have been chosen to
maintain a balance between ensuring the sample is repre-
sentative of the ED population whilst ensuring that the
trial population is able to engage both with the interven-
tions and follow up.
All ED attendees aged 18 or more who score positive for
AUD, who are alert and orientated, live within the local
area of the ED and are able to speak, read and write Eng-
lish sufficiently well to complete study questionnaires are
eligible. Patients are not eligible if they are already seeking
treatment for an AUD or are taking part in another study
of alcohol interventions, if they are severely injured or suf-
fering from a serious mental health problem and/or are
grossly intoxicated. Finally patients with no fixed abode
are excluded from the study.
Randomisation
Randomisation will be conducted using a secure remote
randomisation service. Nine allocations will be generated
for each of the possible factorial combinations of screen-
ing method (SIPS-PAT vs FAST vs M-SASQ) and interven-
tion (PIL vs BA vs BLC). EDs and allocations will be
randomly sampled without replacement and paired to
generate allocation groups. The allocations are detailed in
Table 1.
Screening
In order to test the relative effectiveness of different
screening methods in identifying hazardous and harmful
drinkers we intend to conduct a cluster randomized com-
parison of three established screening tools. A modified
version of the Paddington Alcohol Test (PAT) [9] which
has been routinely used at St. Mary's Hospital Paddington
embedded within the standard clinical assessment proc-
Trial Flow ChartFigure 1
Trial Flow Chart.
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screening conditions but has been shortened to 2 ques-
tions. Question 1 asks "Do you feel your attendance here
is related to your drinking?" if the answer is Yes then the
patient is considered SIPS-PAT positive; if the answer is
No, a further question is asked, "How often do you have
X or more standard drinks on one occasion?" where X = 6
for women and 8 for men, with monthly, weekly or daily
considered a positive screen. The original PAT has under-
gone validity testing in ED as a targeted screening tool and
has been found to have high sensitivity and specificity for
identifying AUD in this population [9]. A modified ver-
sion of the Single Alcohol Screening Questionnaire (M-
SASQ) which asks "How often do you have X or more
standard drinks on one occasion?" where X = 6 for women
and 8 for men, with monthly, or weekly, or daily or
almost daily considered a positive screen. The original
SASQ has undergone validity testing in primary care set-
tings and has a high level of sensitivity and specificity for
alcohol use disorders, although lower than PAT [11,12].
SASQ is shorter than PAT and while it has lower sensitivity
and specificity it may be more acceptable to ED staff. We
tested the M-SASQ in a pilot study and established a sen-
sitivity of 91.8 and specificity of 70.8 when compared to
the gold standard Alcohol Use Disorders Identification
Test (AUDIT). The Fast Alcohol Screening Test (FAST) [7]
is a universal screening tool that has demonstrated high
sensitivity and specificity in ED settings. All screening
tools have been modified to include a visual guide to
interpreting a 'standard drink' which equates to 8 mg of
pure ethanol.
In accordance with best practice all patients who are
attending ED and potentially eligible will be informed of
the study and asked to consent to be screened. They will
be screened using the instrument available within the ED.
Participants will be informed of the outcome of the
screening.
Consent
Consent to participate will be obtained in a 2-stage proc-
ess. ED staff will initially establish verbal consent to check
eligibility to take part, collect some basic demographic
information and consent to be screened. Those who then
are positive on the screening tool will have the study
explained to them verbally by ED staff and in writing
(using the patient information sheet). Written informed
consent will be obtained by ED staff. This will include per-
mission to give the patient's data and contact details to the
research staff, provide the research team with access to the
patients ED records and to participate in follow up after 6
and 12 months. The research team will then contact the
patient within two weeks to thank him/her for taking part
in the study. Participants will receive a £10 retail voucher
after completing the baseline research interview and a £10
voucher for completing each of the 6 and 12 month
research follow-up interview.
Patient information leaflet
In the three EDs randomised to the control condition,
participating staff will be trained to screen eligible
patients for hazardous or harmful drinking and patients
will not have access to a AHW. Patients who screen posi-
tive and provide consent to participate in the study will
complete the baseline questionnaire and then be pro-
vided with a patient information leaflet (PIL) http://
www.sips.iop.kcl.ac.uk. The PIL to be used in this trial will
be the Department of Health's "How much is too much;
Drinking and You" leaflet. This information leaflet con-
tains useful information about alcohol and includes the
Drinkline telephone number where the patient can access
further information including treatment options for alco-
hol problems. A sticker with local alcohol services will
also be attached to the back cover.
Brief advice
In the three EDs randomized to deliver Brief Advice, par-
ticipating staff will be trained to screen eligible patients
for hazardous or harmful drinking. Patients who screen
positive and provide consent to participate in the study
will complete the baseline questionnaire and will then
receive up to five minutes of simple structured brief advice
from trained ED staff or an AHW, using the SIPS Brief
Advice tool "Brief advice about alcohol risk" which has
Table 1: 3 × 3 allocation table
Intervention allocation
PIL BA BLC
Screening allocation FAST AED = 1 AED = 1 AED = 1 AED = 3
n = 131 n = 131 n = 131 n = 393
SASQ AED = 1 AED = 1 AED = 1 AED = 3
n = 131 n = 131 n = 131 n = 393
PAT AED = 1 AED = 1 AED = 1 AED = 3
n = 131 n = 131 n = 131 n = 393
AED = 3 AED = 3 AED = 3 AED = 9
n = 393 n = 393 n = 393 n = 1179Page 5 of 10
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"How much is too much? Simple Structured Advice inter-
vention tool, developed as part of the UK version of the
Drink-Less BI programme [23] from a prototype used as
part of a World Health Organisation collaborative study
on alcohol screening and brief. Patients in this condition
will also receive a Patient Information Leaflet (PIL) at the
end of the brief advice.
Brief lifestyle counselling
In the three EDs randomized to deliver Brief Lifestyle
Counseling, participating staff will be trained to screen eli-
gible patients for hazardous or harmful drinking. Patients
who screen positive and provide consent to participate in
the study will complete the baseline questionnaire and
will then receive up to five minutes of simple structured
brief advice from trained ED staff, using the SIPS Brief
Advice tool "Brief advice about alcohol risk". Patients in
this condition will also receive a Patient Information Leaf-
let (PIL) at the end of the brief advice. ED staff will also be
trained to refer patients to an AHW by making an appoint-
ment usually the following day or as soon as possible after
ED attendance. The AHW will be experienced in carrying
out alcohol assessment and brief interventions. The AHW
will deliver a 20 minute brief lifestyle counseling interven-
tion to patients who attend the appointment at the ED,
using the SIPS Brief Lifestyle Counselling (BLC) Tool
which has been developed for the SIPS programme. It is
based on the "How much is too much?" Extended Brief
Intervention tool developed as part of the UK version of
the Drink-Less BI programme [23] from a prototype used
as part of a World Health Organisation collaborative
study on alcohol screening and brief intervention.
All intervention tools and protocols are available from the
SIPS study website http://www.sips.iop.kcl.ac.uk.
Training of staff in trial protocols and screening for AUDs
All ED staff participating in the trial will be trained to
implement alcohol screening and brief intervention
according to the trial protocol. The aim of the training is
to provide some background information about alcohol
related harm, to give an overview of the study protocol, to
familiarise staff with the screening tools, structure and
scoring procedures, and to inform staff about the proce-
dure for implementing screening and brief intervention at
their site. Given the cluster design of the trial, staff will
only be introduced to the screening tool they have been
randomly allocated to. The training is individualised
according to the implementation procedure agreed with
the local collaborator and senior colleagues in the ED.
A substantial element of the training involves the under-
standing of and familiarisation with alcohol units to
ensure that the practitioners are fully aware of the alcohol
content of different alcoholic drinks so they are able to
complete the screening tools accurately. Moreover, as the
screening tools refer to standard drinks rather than units
when assessing consumption, the training ensures staff
are aware that a standard drink is one unit and that they
are able to convert different drinks into the number of
standard drinks e.g. one pint of premium lager equals
three standard drinks (or three units). Visual representa-
tions of standard drinks as well as several examples of
people's drinking patterns are used to allow trainees to
practice calculating units in each drink and to add up the
number of standard drinks/alcohol units consumed in
order to identify positive cases.
Training of staff to deliver brief advice
Participating staff selected to deliver brief advice in EDs
randomised to either the Brief Advice (BA) condition or
the Brief Lifestyle Condition (BLC) will receive a one hour
training session on how to deliver five minutes of brief
advice according to the protocol.
The aim of the training is to provide practitioners with the
skills necessary to effectively deliver brief advice about
alcohol risk to patients attending the ED in which they
work. The training was developed by the SIPS team to be
delivered by an AHW. The AHWs in the SIPS team are
experienced practitioners in the field of alcohol treatment.
They contributed to the development of the training pack-
age and have been fully trained to deliver the training to
practitioners.
The standard training package is based on a PowerPoint
presentation with scripts to standardise delivery. The
training sessions are adapted for use in the different exper-
imental conditions in which BA is being delivered.
The session will be presented to small groups of clinicians
who are encouraged to interact with the trainer, ask ques-
tions and comment on the content. This is followed by an
interactive role play session in which the AHW demon-
strates the intervention and each practitioner then has an
opportunity to practice with a co-worker, observed by the
trainer who provides feedback and encouragement. Train-
ing sessions are delivered to groups of 1–10 practitioners
with 3–4 being the typical group size. However, some EDs
require larger groups due to the higher number of partici-
pating staff.
Training of staff to deliver brief lifestyle counselling
AHWs will be recruited to deliver the BLC within the ran-
domised EDs. Staff recruited will, as a minimum, possess;
a relevant professional qualification, a diploma in drug
and/or alcohol studies or equivalent, 5 years post-qualify-
ing experience with a minimum 2 years in an alcohol or
drug speciality, prior knowledge and understanding ofPage 6 of 10
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viewing.
All AHWs will receive formal training and supervision
from the point of recruitment. Training will be based
upon the previous work of Rollnick et al [24] in addition
to experiences from an earlier trial of screening and brief
interventions [25]. The training will comprise four main
elements: orientation to the relevant ED, taught work-
shops, tape recorded simulated consultations with trained
actors and ongoing clinical supervision provided by expe-
rienced senior clinicians.
The simulated consultations will be recorded and rated by
three independent clinical assessors. The AHW will be
assessed for adherence to the BLC protocol in addition to
their behaviour and skills using the Behaviour Change
Counselling Index (BECCI) [26]. Assessors will submit
BECCI ratings, comments and supervision points for each
consultation. This information will support clinical super-
vision and training until the AHW reaches a required
standard of practice agreed by an independent clinical
assessor.
Primary outcome measure
The primary outcome measure for the study is the score
on the AUDIT screen at 12 months post-consent. This
screen is ascertained using the Extended AUDIT [27] a
modified form of the AUDIT that exhibits similar sensitiv-
ity and specificity to AUDIT.
Secondary outcome measures
1. Average drinks, where a drink equates to 8 mg of pure
ethanol per day at baseline and 6 and 12 months will be
established using the quantity-frequency questions of the
Extended AUDIT. 2. Health utility will be measured at
baseline, 6 and 12 months using the EQ-5D [28]. 3. Serv-
ice Use Questionnaire will be used to measure service uti-
lisation at baseline, 6 and 12 months. 4. An adapted
readiness to change ruler validated for use in this study
[29] measured at baseline, 6 and 12 months. 5. Alcohol
related problems will be assessed using the Alcohol Prob-
lems Questionnaire at 6 and 12 months [30]. 6. Patient
satisfaction with the advice received during the interven-
tion will be assessed using a modified version of the
Patient Satisfaction Questionnaire (short form) at 12
months [31].
Economic outcome measures
Screening costs will be estimated using the actual costs of
screening using the actual costs of screening associated
with the study. Costs of delivering the interventions will
be based upon actual patient contact time from time
sheets maintained by staff. The units of services used will
be based upon local costs of services and include allow-
ances for managerial and premises overheads and the
costs associated with training and supervision using meth-
ods utilised in similar intervention studies [32]. The costs
of any specialist referral will be ascertained using informa-
tion on the actual costs associated with specialist service
provision based upon Department of Health costs of spe-
cialist interventions [33]. Participant use of health serv-
ices, other alcohol services outside the study, public
services and criminal justice services will be assessed using
a Service Use Questionnaire at baseline, 6 and 12 months
post consent. This has been developed over a number of
alcohol intervention studies and will be adapted to cap-
ture costs specifically associated with this population.
Quality assurance and process measures
Attendance for brief lifestyle advice on the part of the cli-
ent will be recorded by the AHW. During the course of the
study AHW will receive continuing supervision from sen-
ior members of the clinical team replicating ongoing qual-
ity assurance in clinical practice. At the end of the trial all
AHWs who delivered brief lifestyle counseling will partic-
ipate in simulated consultation and these in turn will be
rated by three independent raters using BECCI. This infor-
mation will be utilized to establish both adherence to the
BLC protocol and as a measure of quality assurance in the
analysis.
Sample size calculation
The sample size calculation is designed to account prima-
rily for intervention level outcomes. Powering the study in
this way will also account statistically for appropriate out-
comes for screening approach and screening method. The
primary outcome for this study is the proportion of
patients who consume alcohol within recommended lev-
els at 12 month follow up. Recent meta-analysis [14] sug-
gests that the difference between brief intervention and
control is of the order 13%, 5% reduction in the control
group and 18% in the brief intervention group. In order
to detect a difference of this magnitude at the 5% signifi-
cance level with 80% power, for a 2-sided test, requires
109 patients in each of the 3 groups, a total of 327. Our
experience with other multi-centre randomized control-
led trials of interventions for alcohol use disorders sug-
gests that with assiduous follow-up the potential loss to
follow-up across groups is of the order 25%. Taking this
loss into accounts inflates the sample required to 131 in
each group, a total of 393 patients.
The proposed study involves a cluster design and requires
a statistical adjustment to account for any potential cluster
effect. The literature and our previous experience of trials
in primary care suggest that an intra-class correlation coef-
ficient of 0.04 is appropriate. Assuming a cluster size of
the order 44 patients, this inflates the sample size calcula-
tion by a factor of 2.7 requiring a total of 1179 patients,Page 7 of 10
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will be followed up at 6 months and 12 months. We pro-
pose to recruit 9 EDs. ED populations will be screened
using 1 of 3 screening method groups (3 EDs in each
group) and will receive 1 of 3 interventions (3 EDs in each
group). Our estimates using data from previous studies
suggest that a conservative estimate of 15% of those
approached will be eligible and consent. In order to iden-
tify 131 eligible and consenting participants, 870 partici-
pants will be approached in each of the EDs a total of
7830.
Effectiveness analysis
As the study is pragmatic in design, the planned analysis
will be by intention to treat. The primary outcome is
dichotomous in nature, drinking within or above recom-
mended levels, and will be analysed through a logistic
regression adjusting for all known prognostic factors.
Data will be presented as odds ratios and their corre-
sponding 95% confidence intervals. Secondary analyses
will be undertaken using the appropriate method for the
outcomes, controlling where appropriate for intake values
and other known prognostic variables using analysis of
covariance. We will assess the sensitivity and specificity of
each screening approach by generation of receiver opera-
tor curves and comparison with the gold standard AUDIT
screening tool. Simulations will be undertaken to encom-
pass both screening approach groups and intention to
treat analysis will be undertaken on both groups. Due to
the nested factorial nature of the study, we will use multi-
level modelling to explore potential interactions between
each of the levels nested within the trial.
ED and patient factors will be utilised as part of regression
model to explore possible prognostic factors that impact
on outcome. Interaction analysis will explore any possible
interactions between ED and patient characteristics and
outcome. The efficacy of the interventions will be
explored with a secondary analysis utilising a per protocol
approach. A sub-group of the trial population, those who
engaged in the allocated treatment, will be utilised for this
analysis.
Cost-effectiveness analysis
The economic component of the study comprises a cost-
effectiveness and cost-utility analysis. The study aims to
identify, quantify and value resources related to alcohol
screening and intervention by clinicians in ED and the
subsequent use of health, social care and criminal justice
services by patients following each type of intervention.
Resources utilised in the identification and brief interven-
tion delivery or control condition will be recorded by ED
staff involved on an ongoing basis. This will allow the cal-
culation of costs related to implementation of different
models of screening and brief intervention. Local costs
will be used to calculate the costs of the interventions,
which will include staff costs, premises costs and costs of
leaflets and other consumables. In addition, specific train-
ing costs for staff will be calculated in terms of staff time,
premises costs and the cost of training materials.
Patients' use of health, social care and criminal justice
services will be identified retrospectively using a short
form of the Service Use Questionnaire previously used to
evaluate costs associated with interventions for alcohol
use disorders and applying a common set of national unit
cost estimates. The economic analysis will calculate the
incremental cost-effectiveness of the control condition
with the AHW condition under study, using measures of
clinical outcome and quality of life, EQ-5D responses at
baseline, 6 and 12 month follow up. The use of EQ-5D
enables the estimation of Quality Adjusted Life Years.
Data will be bootstrapped to account for the expected
skewness evident in economic cost data [34]. The analysis
will include the construction of cost-effectiveness accepta-
bility curves to illustrate the probability that the brief
intervention is more cost-effective than usual care, based
on different monetary values being attached to QALYs.
The use of QALYs follows the recommendations of NICE
and enables the value for money afforded by treatment to
be compared to a range of other health care interventions.
Furthermore, combination of the economic cost data and
outcome data with patient data collected in the trial will
enable a secondary analysis of various patient characteris-
tics that may influence the cost-effectiveness of the inter-
vention.
Frequency of analysis
Analysis will be conducted after the final 12 month fol-
low-up has been completed.
Ethics and confidentiality
The study has been granted ethical approval by a multi-
centres research ethics committee and by the local
research ethics committee for the localities where the
research will take place. There are no anticipated risks in
relation to either treatment. There is no documented evi-
dence of adverse events arising from any of the proposed
interventions.
All trial data will be identified using a unique trial identi-
fication number. No personally identifiable information
will be held beyond the final 12 month follow up. Analyt-
ical datasets will not contain any patient identifiable
information. Anonymised data will be retained for a
period of 60 months.
Discussion
This study is part of programme of research being con-
ducted in England to evaluate the implementation, effec-Page 8 of 10
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BMC Health Services Research 2009, 9:114 http://www.biomedcentral.com/1472-6963/9/114tiveness and cost-effectiveness of a variety of approaches
to screening and interventions for hazardous and harmful
alcohol users across emergency departments, primary
health care and criminal justice settings.
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